Previous Page  1260 / 1816 Next Page
Information
Show Menu
Previous Page 1260 / 1816 Next Page
Page Background

Adjuvant! Online

• A version of Adjuvant! Online that will include HER2 status and the potential

benefit of trastuzumab is in development

• Information about the efficacy of different therapy options are derived from

Early Breast Cancer Trialists Collaborative Group (EBCTCG) meta-

analyses in order to provide estimates of reduction in risk at 10 years of

breast cancer related death or relapse for selected treatments

19-9-2017

The basic format of an early version of Adjuvant! was described by Ravdin

Ravdin, Siminoff, Davis, et al. JCO

2001;19(4):980-991